Related Experiment Video

Updated: Jul 19, 2026

Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

Mechanism of HBD-3 deficiency in atopic dermatitis

Michael D Howell1, Mark Boguniewicz, Saveria Pastore

  • 1Division of Allergy and Immunology, Department of Pediatrics, The National Jewish Medical and Research Center, Room K926, 1400 Jackson Street, Denver, CO 80206, USA.

Clinical Immunology (Orlando, Fla.)
|October 4, 2006
PubMed

Insights

Patients with atopic dermatitis (AD) show reduced human beta defensin-3 (HBD-3), an antimicrobial peptide crucial for fighting infections. This deficiency is acquired and linked to elevated Th2 cytokines, suggesting a therapeutic target.

Area of Science:

  • Immunology
  • Dermatology
  • Microbiology

Background:

  • Atopic dermatitis (AD) patients, both extrinsic (EAD) and intrinsic (IAD), experience frequent bacterial and viral infections.
  • Human beta defensin-3 (HBD-3), a key antimicrobial peptide (AMP), plays a vital role in the skin's innate immune defense.

Purpose of the Study:

  • To investigate the expression levels of HBD-3 in the lesional skin of EAD and IAD patients.
  • To determine whether the observed HBD-3 deficiency is a primary genetic trait or an acquired condition.
  • To explore the role of specific cytokines (IL-4, IL-10, IL-13) in regulating HBD-3 expression in AD.

Main Methods:

  • Quantitative analysis of HBD-3 expression in skin lesions from AD patients (EAD and IAD) and psoriasis patients.
  • In vitro studies using primary keratinocytes isolated from EAD and IAD patients.
  • Assessment of the impact of IL-4, IL-10, and IL-13 on HBD-3 expression in keratinocytes.
  • In vivo experiments using EAD skin explants treated with cytokine-neutralizing antibodies.

Main Results:

  • Significantly decreased HBD-3 expression was observed in the lesional skin of both EAD and IAD patients compared to psoriasis patients (p<0.01).
  • Keratinocyte studies revealed that the HBD-3 deficiency in AD is an acquired defect, not a constitutive one.
  • Over-expressed Th2 cytokines (IL-4, IL-10, IL-13) in AD skin were found to down-regulate HBD-3 expression in keratinocytes.
  • Treatment of EAD skin explants with antibodies against IL-4, IL-10, and IL-13 led to increased HBD-3 expression.

Conclusions:

  • The reduced expression of HBD-3 in atopic dermatitis contributes to increased susceptibility to infections.
  • Elevated levels of IL-4, IL-10, and IL-13 in AD skin suppress the innate immune response by inhibiting HBD-3.
  • Neutralizing these Th2 cytokines in AD skin holds potential for enhancing the innate immune defense against pathogens.

More Related Videos

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment06:47

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment

Published on: September 27, 2017

Related Concept Videos

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
Pedigree Analysis01:35

Pedigree Analysis

Overview
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...